DelMar Pharmaceuticals, Inc. DMPI Balance Sheet

Delmar pharmaceuticals, inc. (DMPI)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11
Assets
Current assets
Cash and cash equivalents
4,973	6,348	8,060	3,718	2,152	3,702	3,884	5,971	8,506	11,021	13,156	6,586	2,100	3,417	4,799	6,157	937	1,957	2,804	1,754	3,006	3,958	4,315	4,759	3,474	4,136	5,170	6,282	7,532	17	-	1	2	0	-	-
Prepaid expenses and deposits
114	122	223	280	240	306	831	1,034	1,072	1,140	1,216	1,208	119	130	177	144	85	167	191	245	357	155	162	234	269	170	210	221	83	28	-	-	-	-	-	-
Interest, taxes and other receivables
10	30	70	26	9	10	11	39	62	24	40	76	70	17	38	18	32	16	35	25	49	14	19	9	10	11	11	16	76	45	-	-	-	-	-	-
Deferred financing costs
-	-	-	-	40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred costs
-	-	-	-	-	-	-	-	-	-	-	-	25	-	-	-	60	0	0	550	-	-	-	0	-	0	0	0	0	90	-	-	-	-	-	-
Current assets
5,098	6,501	8,354	4,025	2,442	4,019	4,728	7,046	9,641	12,187	14,413	7,870	2,316	3,566	5,014	6,319	1,115	2,140	3,031	2,575	3,413	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible assets - net
3	6	9	12	14	17	21	28	35	29	34	40	24	28	32	36	39	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Web Site Development Costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	6	5
Account Receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	5
Total assets
5,102	6,508	8,363	4,037	2,457	4,037	4,749	7,074	9,676	12,216	14,448	7,911	2,340	3,594	5,046	6,355	1,155	2,184	-	2,575	-	4,128	4,497	5,003	3,754	4,318	5,393	6,521	7,693	182	0	1	2	0	6	10
Liabilities
Current liabilities
Accounts payable and accrued liabilities
1,085	750	1,127	1,744	1,084	1,115	909	1,478	1,890	1,829	1,438	1,182	791	515	405	584	646	479	372	762	486	256	293	244	-	140	-	-	-	677	-	-	-	-	-	-
Accounts payable and accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	404	-	210	431	578	-	-	-	-	-	-	-
Related party payables
296	276	211	325	113	152	168	160	122	397	86	88	70	205	76	43	29	56	38	90	43	37	41	54	35	109	217	236	296	447	-	-	-	-	-	-
Current portion of derivative liability
-	-	-	-	-	-	-	-	0	0	0	33	157	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Due to Officer
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	-	-	-
Current liabilities
-	-	-	-	1,197	1,268	1,077	1,638	2,013	2,227	1,525	1,304	1,019	721	482	627	675	535	411	853	529	294	335	299	440	249	427	667	874	1,125	-	-	9	-	-	-
Loan payable to Valent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	276	274	272	270	268	266	264	-	-	-	-	-	-
Stock option liability
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	175	149	179	179	179	179	180	182	217	241	212	208	311	183	0	-	-	-	-	-	-
Derivative liabilities
-	-	-	-	0	0	1	1	3	5	4	28	91	171	590	693	1,017	1,352	2,954	2,364	1,487	1,567	3,458	5,111	5,857	4,402	4,790	12,986	8,387	121	-	-	-	-	-	-
Accounts Payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	2	2	-	0
Due to Officer
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	7	-	-	-	0
Loan Payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	-
Total liabilities
1,381	1,027	1,338	2,069	1,197	1,268	1,079	1,639	2,017	2,232	1,529	1,332	1,110	892	1,072	1,497	1,842	2,067	3,545	3,396	2,196	2,041	3,976	5,905	6,814	5,136	5,697	14,234	9,712	1,510	12	9	-	4	-	0
Stockholders' equity
Preferred stock
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	278	278	278	278	278	278	278	0	0	0	0	0	0	0	0	0	0	0	0	0
1 special voting share at March 31, 2020 (June 30, 2019 - 1)
-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Common stock Authorized 95,000,000 shares at March 31, 2020 and June 30, 2019, $0.001 par value 11,427,132 issued at March 31, 2020 (June 30, 2019 - 3,839,358)
11	11	11	3	2	26	23	2	22	22	22	14	11	11	11	11	44	44	43	39	39	38	36	35	32	31	31	31	30	13	3	3	3	3	5	5
Additional paid-in capital
56,395	56,263	56,098	50,954	47,022	46,828	43,412	43,198	43,739	43,238	42,956	36,665	31,511	30,821	30,523	28,833	21,805	21,686	18,601	17,363	17,455	16,625	13,982	13,149	9,748	8,791	8,439	7,585	6,466	2,326	-	-	-	-	-	-
Warrants
8,382	8,313	8,279	6,588	6,055	6,046	8,260	8,229	7,478	7,321	7,321	4,570	1,618	1,683	1,683	1,658	1,190	971	777	89	6,138	6,187	6,187	151	6,201	6,202	6,202	6,441	6,441	153	-	-	-	-	-	-
Accumulated other income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-0	-
Accumulated deficit
-65,893	-63,933	-62,188	-60,578	-57,988	-56,299	-54,471	-52,441	-50,028	-47,046	-43,828	-41,118	-38,401	-36,321	-34,837	-32,237	-24,028	-22,885	-20,236	-18,613	-22,715	-	-	-14,259	-	-	-	-	-	-	-	-	-56	-53	-42	-
Accumulated deficit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21,064	19,985	-	19,063	15,864	14,998	21,792	14,979	3,842	-61	-57	-	-	-	-38
Additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45	45	45	45	43	43
Accumulated other comprehensive income
21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	-0	-0	-0	-	-	-0
Total stockholders' equity
3,720	5,480	7,024	1,967	1,259	2,769	3,670	5,435	7,659	9,983	12,918	6,578	1,230	2,702	3,974	4,858	-687	116	-514	-821	1,217	2,086	520	-901	-3,060	-817	-304	-7,712	-2,019	-1,327	-12	-8	-7	-4	6	10
Total liabilities and stockholders' equity
5,102	6,508	8,363	4,037	2,457	4,037	4,749	7,074	9,676	12,216	14,448	7,911	2,340	3,594	5,046	6,355	1,155	2,184	3,031	2,575	3,413	4,128	4,497	5,003	3,754	4,318	5,393	6,521	7,693	182	0	1	2	0	6	10
Series 1 Preferred Stock [Member]
Preferred stock
278	278	278	278	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series 2 Preferred Stock [Member]
Preferred stock
4,524	4,524	4,524	4,699	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series A Preferred Stock [Member]
Preferred stock, value
-	-	-	-	278	278	-	278	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series B Preferred Stock [Member]
Preferred stock, value
-	-	-	-	5,867	5,867	-	6,146	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-